Crinetics Pharmaceuticals Inc’s recent filing unveils that its Chief Med and Dev Officer Pizzuti Dana unloaded Company’s shares for reported $0.64 million on Apr 15 ’24. In the deal valued at $44.47 per share,14,375 shares were sold. As a result of this transaction, Pizzuti Dana now holds 27,786 shares worth roughly $1.31 million.
Then, Struthers Richard Scott sold 40,951 shares, generating $2,013,561 in total proceeds. Upon selling the shares at $49.17, the President & CEO now owns 237,835 shares.
Before that, Okey Stephanie sold 17,500 shares. Crinetics Pharmaceuticals Inc shares valued at $811,650 were divested by the Director at a price of $46.38 per share. As a result of the transaction, Okey Stephanie now holds 6,000 shares, worth roughly $0.28 million.
Citigroup initiated its Crinetics Pharmaceuticals Inc [CRNX] rating to a Buy in a research note published on March 06, 2024; the price target was $68. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid January with a ‘”an Overweight”‘ rating. Jefferies began covering CRNX with “Hold” recommendation on December 21, 2023.
Price Performance Review of CRNX
On Friday, Crinetics Pharmaceuticals Inc [NASDAQ:CRNX] saw its stock jump 0.90% to $47.20. Over the last five days, the stock has gained 12.06%. Crinetics Pharmaceuticals Inc shares have risen nearly 32.66% since the year began. Nevertheless, the stocks have risen 118.82% over the past one year. While a 52-week high of $49.58 was reached on 04/04/24, a 52-week low of $15.76 was recorded on 01/05/24. SMA at 50 days reached $43.63, while 200 days put it at $32.55. A total of 0.68 million shares were traded, compared to the trading of 0.61 million shares in the previous session.
Levels Of Support And Resistance For CRNX Stock
The 24-hour chart illustrates a support level at 46.76, which if violated will result in even more drops to 46.33. On the upside, there is a resistance level at 48.00. A further resistance level may holdings at 48.81. The Relative Strength Index (RSI) on the 14-day chart is 61.27, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.36, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 15.98%. Stochastics %K at 77.68% indicates the stock is a holding.
